Delta inflation: a bias in the design of randomized controlled trials in critical care medicine
Open Access
- 1 January 2010
- journal article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 14 (2), R77
- https://doi.org/10.1186/cc8990
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The Influence of Treatment Effect Size on Willingness to Adopt a TherapyMedical Decision Making, 2009
- Intensive versus Conventional Glucose Control in Critically Ill PatientsThe New England Journal of Medicine, 2009
- Inadequate Dissemination of Phase I Trials: A Retrospective Cohort StudyPLoS Medicine, 2009
- Multicenter, randomized, controlled trials evaluating mortality in intensive care: Doomed to fail?Critical Care Medicine, 2008
- In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter?PLoS Medicine, 2008
- Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trialsBMJ, 2007
- Comparison of Two Fluid-Management Strategies in Acute Lung InjuryThe New England Journal of Medicine, 2006
- Fluid-Management Strategies in Acute Lung Injury — Liberal, Conservative, or Both?The New England Journal of Medicine, 2006
- Intensive Insulin Therapy in the Medical ICUThe New England Journal of Medicine, 2006
- Quality of life in adult survivors of critical illness: A systematic review of the literatureIntensive Care Medicine, 2005